ID: ALA4792523

Max Phase: Preclinical

Molecular Formula: C31H39NO7

Molecular Weight: 537.65

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CC(=O)OCC(C)(C)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1ccccc1

Standard InChI:  InChI=1S/C31H39NO7/c1-6-28(33)38-21-31(2,3)30(35)32-19-11-10-14-24(32)29(34)39-25(23-12-8-7-9-13-23)17-15-22-16-18-26(36-4)27(20-22)37-5/h6-9,12-13,16,18,20,24-25H,1,10-11,14-15,17,19,21H2,2-5H3/t24-,25+/m0/s1

Standard InChI Key:  OJGSIBJYYNFYNB-LOSJGSFVSA-N

Associated Targets(Human)

FK506-binding protein 1A 1014 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 537.65Molecular Weight (Monoisotopic): 537.2727AlogP: 5.06#Rotatable Bonds: 12
Polar Surface Area: 91.37Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.98CX LogD: 5.98
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.28Np Likeness Score: -0.06

References

1. Atack TC,Raymond DD,Blomquist CA,Pasaje CF,McCarren PR,Moroco J,Befekadu HB,Robinson FP,Pal D,Esherick LY,Ianari A,Niles JC,Sellers WR.  (2020)  Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35.,  11  (11): [PMID:33209191] [10.1021/acsmedchemlett.0c00272]

Source